Autoimmune neutropenia is a condition characterized by a low level of neutrophils, a type of white blood cell essential for fighting infections. This disorder can occur in both children and adults ...
In 2019, the global neutropenia treatment market was valued at a staggering $12,602.5 million. This figure encapsulates the substantial demand for innovative therapies aimed at combating ...
The condition can increase the risk of infections. Neutropenia or low levels of neutrophils, primarily results from chemotherapy. It could also result from conditions that disrupt normal ...
Suggestions regarding when it is appropriate to initiate chemotherapy-induced neutropenia prophylaxis in patients with cancer and goals of therapy. January 18th 2021EP. 5: Chemotherapy-Induced ...
Late-onset neutropenia (LON) is emerging as a common adverse effect to rituximab therapy owing to widespread use of this drug in the treatment of B-cell lymphomas and autoimmune diseases.
Objective: To systematically evaluate the literature to determine whether vancomycin-induced neutropenia is dose- or duration-related and provide clinicians with feasible treatment alternatives.